We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Commenters Cite Concerns Over FDA’s Breakthrough Devices Draft Guidance
Commenters Cite Concerns Over FDA’s Breakthrough Devices Draft Guidance
The FDA has drawn mixed reactions to its draft guidance on reducing healthcare disparities in its Breakthrough Devices program, including support for creating greater flexibility for entry into the program, but also concerns about approvals that might lack sufficient evidence and ultimately jeopardize patient safety.